Skip to main content
Signal8

Namouni Fouad

SEC insider (Form 3/4/5 filer). CIK 0001815851. Director at Vor Biopharma Inc. (VOR) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in BOSTON, MA.

Companies Namouni Fouad has filed insider reports for

  • Vor Biopharma Inc. (VOR): Director
  • Blueprint Medicines Corp (BPMC): Officer, PRESIDENT, R & D
Namouni Fouad profile photo

Namouni Fouad

CIK: 0001815851

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (25.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Vor Biopharma Inc. logo
VOR

Vor Biopharma Inc.

Director
Blueprint Medicines Corp logo
BPMC

Blueprint Medicines Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

  • Vor Biopharma Inc. logo
    VOR

    Vor Biopharma Inc.

    Jun 11, 2026
    Award

    Stock Option (right to buy)

    Direct
    56.5K shares-
  • Blueprint Medicines Corp logo
    BPMC

    Blueprint Medicines Corp

    Jul 17, 2025
    Disposition
    Direct
    83.3K shares-
  • Blueprint Medicines Corp logo
    BPMC

    Blueprint Medicines Corp

    Jul 17, 2025
    Tender Offer
    Direct
    32K shares-
  • Blueprint Medicines Corp logo
    BPMC

    Blueprint Medicines Corp

    Jul 17, 2025
    Award
    Direct
    39.5K shares-
  • Vor Biopharma Inc. logo
    VOR

    Vor Biopharma Inc.

    May 22, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    30K shares-
  • Blueprint Medicines Corp logo
    BPMC

    Blueprint Medicines Corp

    Mar 5, 2025
    Sale
    Direct
    6.5K shares at avg. $88.80$576K
  • Blueprint Medicines Corp logo
    BPMC

    Blueprint Medicines Corp

    Mar 1, 2025
    Award
    Direct
    13.2K shares-
  • Blueprint Medicines Corp logo
    BPMC

    Blueprint Medicines Corp

    Oct 3, 2024
    Sale
    Direct
    3.6K shares at avg. $89.32$324K

1-8 of 8